Search research articles
Contact Us
Filters
Showing results (101-110 of 158) with videos related to
Page
of 16
Sort By:
Discover Oncology
|
October 2, 2025
Gut microbiota and urological cancers: from microecological imbalance to potential for precision therapy
Junfeng Cui, Hong Chen, Fengming Dong, et al.
Oncology Research
|
April 16, 2013
LRIG1 enhances cisplatin sensitivity of glioma cell lines
Xiongwei Wang, Qungen Xiao, Xihong Xing, et al.
Clinical Pharmacology in Drug Development
|
February 28, 2026
Pharmacokinetic Characterization and Bioequivalence of Sildenafil Citrate Orally Disintegrating Tablets in Healthy Volunteers
Yi Zhang, Lijie Du, Shirong Liu, et al.
Oncology Reports
|
November 6, 2012
Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation
Ruifan Xie, Hai Yang, Qungen Xiao, et al.
Gene Expression
|
July 4, 2007
Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver
Joy Sarkar, Chao Qi, Dongsheng Guo, et al.
Scientific Reports
|
June 11, 2017
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9
Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, et al.
International Journal of Oncology
|
January 11, 2022
[Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells <i>in vitro</i> and <i>in vivo</i> through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
International Journal of Oncology
|
July 18, 2018
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
International Journal of Oncology
|
January 23, 2013
A role for LRIG1 in the regulation of malignant glioma aggressiveness
Feng Mao, Baofeng Wang, Qungen Xiao, et al.
International Journal of Oncology
|
April 4, 2019
[Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 158) with videos related to
Sort By:
Page
of 16
Discover Oncology
|
October 2, 2025
Gut microbiota and urological cancers: from microecological imbalance to potential for precision therapy
Junfeng Cui, Hong Chen, Fengming Dong, et al.
Oncology Research
|
April 16, 2013
LRIG1 enhances cisplatin sensitivity of glioma cell lines
Xiongwei Wang, Qungen Xiao, Xihong Xing, et al.
Clinical Pharmacology in Drug Development
|
February 28, 2026
Pharmacokinetic Characterization and Bioequivalence of Sildenafil Citrate Orally Disintegrating Tablets in Healthy Volunteers
Yi Zhang, Lijie Du, Shirong Liu, et al.
Oncology Reports
|
November 6, 2012
Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation
Ruifan Xie, Hai Yang, Qungen Xiao, et al.
Gene Expression
|
July 4, 2007
Transcription coactivator PRIP, the peroxisome proliferator-activated receptor (PPAR)-interacting protein, is redundant for the function of nuclear receptors PParalpha and CAR, the constitutive androstane receptor, in mouse liver
Joy Sarkar, Chao Qi, Dongsheng Guo, et al.
Scientific Reports
|
June 11, 2017
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9
Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, et al.
International Journal of Oncology
|
January 11, 2022
[Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells <i>in vitro</i> and <i>in vivo</i> through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
International Journal of Oncology
|
July 18, 2018
LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
International Journal of Oncology
|
January 23, 2013
A role for LRIG1 in the regulation of malignant glioma aggressiveness
Feng Mao, Baofeng Wang, Qungen Xiao, et al.
International Journal of Oncology
|
April 4, 2019
[Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling
Qungen Xiao, Minhai Dong, Fangling Cheng, et al.
Page
of 16